Journals / Turkish Neurosurgery / 2017 / Cilt: 27 - Sayı: 4

The Effect of Memantine on Functional Recovery of the Sciatic Nerve Crush Injury in Rats

Pages
641–647
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RESUlTS: Results showed that Memantine has no significant effect on regeneration process rate and functional recovery quality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIm: Following severe peripheral nerve injury (PNI), regeneration is often insufficient and functional recovery is incomplete.
📊
Key Findings & Data:We evaluated the effects of Memantine against sciatic nerve crush injury in male Wistar Rats. mATERIAl and mEThODS: Memantine or vehicle was given parenteraly to rats for 7 days postoperative.
💡
Conclusion & Impact:RESUlTS: Results showed that Memantine has no significant effect on regeneration process rate and functional recovery quality.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

AIm: Following severe peripheral nerve injury (PNI), regeneration is often insufficient and functional recovery is incomplete. In this regard, glutamate N-methyl-D-aspartate (NMDA) receptor antagonist such as Memantine have been shown to have neuroprotective effects. We evaluated the effects of Memantine against sciatic nerve crush injury in male Wistar Rats. mATERIAl and mEThODS: Memantine or vehicle was given parenteraly to rats for 7 days postoperative. In Memantine treatment groups, a single dose of agent (5 and 10 mg/kg) was administered daily. The control group was given vehicle in the same manner. The rats were subjected to crush injury in the left sciatic nerve with non-serrated clamp for 30 seconds. Behavioural, electrophysiological and morphological alterations were evaluated during the experimental period. RESUlTS: Results showed that Memantine has no significant effect on regeneration process rate and functional recovery quality. In the sciatic functional index (SFI) test no significant difference was observed between Memantine treatment groups (5 and 10 mg/kg) at any week. CONClUSION: Since the major neuroprotective effect of Memantine is due to its protective activity against NMDA receptormediated excitotoxicity, it seems that glutamate excitotoxicity is less important in motor impairment due to sciatic nerve crush injury. It is clear that more research is needed to confirm these findings

🔖

Cite This Article

GHAYOUR, M., ABDOLMALEKI, A., BEHNAM-RASSOULI, M. (2017). The Effect of Memantine on Functional Recovery of the Sciatic Nerve Crush Injury in Rats. Turkish Neurosurgery, Cilt: 27 - Sayı: 4, 641–647. https://ajindex.com/articles/404540

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P: Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15(4): 961-973, 1995 2. Azkue JJ, Zimmermann M, Hsieh TF, Herdegen T: Peripheral nerve insult induces NMDA receptor-mediated, delayed degeneration in spinal neurons. Eur J Neurosci 10(6): 2204- 2206, 1998 3. Bain J, Mackinnon S, Hunter D: Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plast Reconstr Surg 83(1): 129-136, 1989 4. Basbaum AI, Bautista DM, Scherrer G, Julius D: Cellular and molecular mechanisms of pain. Cell 139(2): 267-284, 2009 5. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-Daspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci 92(16): 7162-7166, 1995 6. Carlton SM, Hargett GL: Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats. Neurosci Lett 198(2): 115-118, 1995 7. Chen H-S, Wang Y, Rayudu P, Edgecomb P, Neill J, Segal M, Lipton SA, Jensen FE: Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following postischemic administration and do not block maze learning or long-term potentiation. J Neurosci 86(4): 1121-1132, 1998 8. Daneyemez M, Solmaz I, Izci Y: Prognostic factors for the surgical management of peripheral nerve lesions. Tohoku J Exp Med 205(3):269-275, 2005 9. Danysz W, Parsons CG: The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease: Preclinical evidence. Int J Geriatr Psychiatry 18: S23-S32, 2003 10. Dijkstra JR, Meek MF, Robinson PH, Gramsbergen A: Methods to evaluate functional nerve recovery in adult rats: Walking track analysis, video analysis and the withdrawal reflex. J Neurosci Methods 96(2):89-96, 2000 11. Ehrlich M, Knolle E, Ciovica R, Böck P, Turkof E, Grabenwöger M, Cartes-zumelzu F, Kocher A, Pockberger H, Fang C, Wolner E, Havel M: Memantine for prevention of spinal cord injury in a rabbit model. J Thorac Cardiovasc Surg 17(2): 285-291, 1999 12. El Nasr MS, Peruche B, Roβberg C, Mennel HD, Krieglstein J: Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 185(1